Ligand · XN2
XN2 · N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phe nylethyl)-pentanamide
XN2, N-[2-hydroxy-1-indanyl]-5-[(2-tertiarybutylaminocarbonyl)-4(benzo[1,3]dioxol-5-ylmethyl)-piperazino]-4-hydroxy-2-(1-phe nylethyl)-pentanamide (C39 H50 N4 O6, 670.8 g/mol), in the MolNFT structures on GenesisL1: bound in 2 records (1…
- Component
- XN2
- Formula
- C39 H50 N4 O6
- Class
- ligand
- Structures
- 2
- PDB entries
- 1
Binding sites
XN2 in 2 structures; the first of them:
- 1K6V · Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease · XN2 B252 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32 and 23 more
- 1K6V · Lack of synergy for inhibitors targeting a multi-drug resistant HIV-1 protease · XN2 B252 · binds ARG8, LEU23, ASP25, GLY27, ALA28, ASP29, ASP30, VAL32 and 23 more
Residues it binds most
ASP 2, GLY 2, ILE 2, VAL 2, THR 2, ALA 2, ARG 2, PRO 2, LEU 2, PHE 2 (residue and the binding sites it lines).
Found with
- ACT · Acetate ion
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.